Elsevier Inc.

SHERPA: Unknown

People

  1. Abu-Rustum
    Abu-Rustum
  2. Chi
    Chi
  3. Lee
    Lee
  4. Giralt
    Giralt
  5. Mulhall
    Mulhall
  6. Perales
    Perales
  7. Sonoda
    Sonoda
  8. Leitao
    Leitao
  9. Yorke
    Yorke
  10. Wu
    Wu

Groups

  1. Department of Medicine (4611)
  2. Surgery (3547)
  3. Survivorship Research (2657)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2123)
  6. GSK Faculty (1936)
  7. Center for Hematologic Malignancies (1671)
  8. Hematologic Malignancies, Division of (1608)
  9. Gynecology Disease Management Team (1426)
  10. Sloan Kettering Institute Faculty (1398)
Search Within
Formats
  1. Journal Article (7389)
  2. Meeting Abstract (4692)
  3. Review (616)
  4. Book Section (538)
  5. Editorial (251)
  6. Conference Paper (138)
  7. Correspondence (92)
  8. Guidelines (82)
  9. Research Letter (29)
  10. Miscellaneous (15)
  11. Book Whole (14)
Groups
  1. Department of Medicine (4611)
  2. Surgery (3547)
  3. Survivorship Research (2657)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2123)
  6. GSK Faculty (1936)

More Groups

People
  1. Nadeem Abu-Rustum (464)
  2. Dennis Chi (420)
  3. Nancy Lee (409)
  4. Michael Zelefsky (401)
  5. Sergio Giralt (384)
  6. John Mulhall (377)

More People

Years
  1. 2025 (253)
  2. 2024 (783)
  3. 2023 (760)
  4. 2022 (794)
  5. 2021 (723)
  6. 2020 (714)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2611)
  2. Gynecologic Oncology (1197)
  3. Journal of Thoracic Oncology (968)
  4. Biology of Blood and Marrow Transplantation (815)
  5. European Journal of Cancer (525)
  6. Journal of Sexual Medicine (435)

More Publications

Results (13856)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1/2 study of BLU-451, a small molecule inhibitor of EGFR, in EGFR exon 20 insertion-mutant incurable advanced cancers
    Meeting Abstract

    Spira, A.; Yu, H.; Sun, L.; Nguyen, D.; Parepally, J.; Albayya, F.; Patel, S.; Zhang, H.; Zalutskaya, A.; Le, X.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1/2 study of BLU-701, a highly selective EGFR inhibitor, in patients with EGFR-mutant non-small cell lung cancer
    Meeting Abstract

    Spira, A.; Spigel, D. R.; Camidge, R.; de Langen, A. J.; Kim, T. M.; Goto, K.; Elamin, Y.; Shum, E.; Reckamp, K. L.; Rotow, J.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • NVL-520, a highly selective ROS1 inhibitor, in patients with advanced ROS1-positive solid tumors: The phase 1/2 ARROS-1 study
    Meeting Abstract

    Drilon, A.; Ou, S. H. I.; Gadgeel, S.; Johnson, M.; Spira, A.; Lopes, G.; Besse, B.; Felip, E.; van der Wekken, A. J.; Calles, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • External validation of a novel CT-based prognostic radiomic signature in patients with metastatic NSCLC in SWOG S0819 phase III randomized trial
    Meeting Abstract

    Dercle, L.; Gomez, D.; Zhao, B.; Kelly, K.; Herbst, R. S.; Redman, M. W.; Gandara, D. R.; Schwartz, L. H.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Phase II NAUTIKA1 study of targeted therapies in stage II-III NSCLC: Preliminary data of neoadjuvant alectinib for ALK+ NSCLC
    Meeting Abstract

    Lee, J. M.; Sepesi, B.; Toloza, E. M.; Pass, H. I.; Lin, J.; Johnson, B. E.; Heymach, J. V.; Johnson, M. L.; Ding, B.; Schulze, K.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Circulating tumor DNA to identify genomic biomarkers of radiation sensitivity in locally advanced non-small cell lung cancer
    Meeting Abstract

    Lebow, E.; Li, B. T.; Sheverdian, N.; Eichholz, J.; Kratochvil, L. B.; Gelblum, D. Y.; Simone, C. B. 2nd; Shepherd, A. F.; Shin, J. Y.; Rimner, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Planned interim analysis of a phase II trial of concurrent durvalumab and radiation therapy for locally advanced lung cancer
    Meeting Abstract

    Rimner, A.; Fitzgerald, K.; Iqbal, A. N.; Shepherd, A. F.; Gomez, D. R.; Shin, J. Y.; Gelblum, D. Y.; Hajj, C.; Albrecht, F.; Kotecha, R. R.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Phase III randomized trial on surgery, chemo and pleural radiation (IMPRINT) for resectable pleural mesothelioma (NRG LU-006)
    Meeting Abstract

    Rimner, A.; Hu, C.; Simone, C. B. 2nd; Rusch, V. W.; Zauderer, M. G.; Gill, R. R.; Yorke, E. D.; Li, Z.; Voong, K. R.; Peikert, T.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Mutations in CREBBP are associated with local failure after lung stereotactic body radiation therapy
    Meeting Abstract

    Ng, V.; Rimner, A.; Sidiqi, B.; Lebow, E. S.; Shaverdian, N.; Gelblum, D. Y.; Shepherd, A. F.; Simone, C. B. 2nd; Gomez, D. R.; Wu, A. J.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • A deep learning auto-segmentation tool for cardiac substructures in 4D radiotherapy planning for locally advanced lung cancer
    Meeting Abstract

    Walls, G. M.; Giacometti, V.; Apte, A.; Thor, M.; McCann, C.; Hanna, G. G.; O'Connor, J.; Deasy, J. O.; Hounsell, A. R.; Butterworth, K. T.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save